Skip to content

To verify the effectiveness of Juglans regia in cases of Acne vulgaris

To verify the effectiveness of Juglans regia in cases of Acne vulgaris: An Interventional Uncontrolled Clinical Trial - Nil

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/083507
Enrollment
33
Registered
2025-03-26
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L700- Acne vulgaris

Interventions

Intervention1: JUGLANS REGIA: POTENCY SELECTED ON THE BASIS OF SUSCEPTIBILITY OF PATIENT 6X,6C,30C,200C TWICE A DAY Control Intervention1: NOT APPLICABLE: NOT APPLICABLE

Sponsors

Patel Hetalben Pravinbhai
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.The cases where the Acne Vulgaris in form of comedones, papules, pustules and nodules of varying degree of inflammation and depth. 2.Patient of age group 12-40 years will be screened irrespective of gender. 3.The cases with Acne vulgaris where Juglans regia is indicated will be included. 4.All participants must provide informed consent to participate in the study and follow homoeopathic treatment protocol.

Exclusion criteria

Exclusion criteria: 1.Individual with skin disorders other than Acne vulgaris will be excluded. 2.Individuals who have used topical or systemic acne medication, including antibiotics or hormonal treatments with in last 1 month will be excluded. 3.Pregnant or Breast feeding individual will not participate due to hormonal fluctuations.

Design outcomes

Primary

MeasureTime frame
GAGSTimepoint: At the baseline and evaluated in each follow up.

Secondary

MeasureTime frame
NOT ANYTimepoint: NOT ANY

Countries

India

Contacts

Public ContactPatel Hetalben Pravinbhai

Dr V H Dave Homeopathic Medical College

dr.sonal2705@gmail.com9426432585

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026